Skip to content
OpenSampling

2025 · Journal of general and family medicine · open access

Comparison between point-of-care testing from capillary samples and conventional laboratory testing from venous samples for white blood cells and C-reactive protein in a pediatric outpatient setting

Kuniyoshi et al.

The finding, in our words

In 277 paediatric patients, capillary microsampling with the Microsemi CRP device found close agreement with venous testing for CRP, with a mean difference of -0.25 mg/dL and 95% limits of -2.1 to 1.6 mg/dL. WBC showed a bias of -18 × 100/μL, with 95% limits of -73 to 37 × 100/μL. This supports decentralised, patient-centric screening of febrile children.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2026

    Capillary dried blood spots, after haematocrit-dependent conversion, showed good agreement with plasma for 25-hydroxyvitamin D quantification, with 90 per cent of results within 20 per cent of plasma and substantial to almost perfect agreement in status classification, supporting reliable home self-collection for large-scale vitamin D monitoring.

    Clinical validation of a DBS-based LC-MS/MS method for 25-hydroxyvitamin D: from lab sampling to home samplingHeughebaert et al., Clinical chemistry and laboratory medicine (paywalled) · source ↗

    • venous-agreement
    • blood
    • dbs
    • self-collection
    • haematocrit
    • dried
    • capillary
    • validation
    • biomarkers
  2. 2026

    The study found that capillary dried plasma spots correlated strongly with venous plasma for detecting the Alzheimer's disease biomarker p-tau217. This suggests that microsampling offers a viable, minimally invasive alternative to venipuncture for screening and monitoring Alzheimer's disease pathology.

    A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathologyHuber et al., Nature medicine · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • venous-agreement
    • biomarkers
  3. 2026

    The homeRNA capillary blood collection and stabilization platform successfully captured lipopolysaccharide-induced inflammatory gene expression profiles. These transcriptomic responses were comparable to those obtained from traditional venous blood samples stabilized with RNAlater or PAXgene, demonstrating the platform's suitability for remote transcriptomic monitoring.

    From Home to Transcriptome: Comparing the Transcriptomic Profile of Induced Immune Response via Lipopolysaccharide Stimulation in homeRNA and Venous BloodBrown et al., Analytical chemistry (paywalled) · source ↗

    • venous-agreement
    • stabilised
    • blood
    • capillary
    • liquid
    • validation
    • biomarkers
  4. 2026

    Self-collected capillary blood samples posted by standard mail showed high concordance with couriered venous samples for HbA1c, creatinine and lipid parameters, supporting their use for remote monitoring in diabetes management and screening.

    Concordance of HbA1c, creatinine, LDL cholesterol, HDL cholesterol, and total cholesterol between venous and self-collected capillary blood samples sent by mailHoffmeister et al., Journal of diabetes investigation · source ↗

    • venous-agreement
    • blood
    • self-collection
    • capillary
    • liquid
    • validation
    • biomarkers
  5. 2026

    Fingerstick capillary sampling showed strong agreement with venous sampling for mycophenolic acid, tacrolimus and cyclosporine A, with acceptable bias and improved agreement for mycophenolic acid after haematocrit correction. This minimally invasive approach may reduce procedural burden and support outpatient or home based therapeutic drug monitoring in children.

    Minimally Invasive Therapeutic Drug Monitoring of Immunosuppressants in Children with Kidney Diseases: Validation of Fingerstick Sampling Using LC-MS/MSIshii et al., Pharmaceuticals · source ↗

    • venous-agreement
    • blood
    • tdm
    • haematocrit
    • capillary
    • pediatric
    • immunosuppressants
    • validation